Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miriam Velasco-Sidro
Institutions:
Research Institute Hospital 12 de Octubre,
Hospital Universitario 12 De Octubre,
University of Pennsylvania
Observed institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre,
University of Pennsylvania
ORCID:
0009-0001-2304-5741
Observed ORCID:
0009-0001-2304-5741
OpenAlex ID:
A5099012838
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression
2025
·
Javier Arroyo-Ródenas
, Aida Falgas
, et al.
·
Journal for ImmunoTherapy of Cancer
·
16
Dual-targeted STAb-T cells secreting BCMA and CD19 T cell engagers for improved control of haematological cancers
2024
·
Miriam Velasco-Sidro
, Javier Arroyo-Ródenas
, et al.
·
OncoImmunology
·
10
Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.
2024
·
Javier Arroyo-Rodenas
, Laura Díez-Alonso
, et al.
·
Journal of Clinical Oncology
·
4
PDF
Common variable immunodeficiency: B cells' impairment in an in vitro assay
2026
·
Daniel Arroyo-Sánchez
, Marta Chivite-Lacaba
, et al.
·
Journal of Translational Medicine
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection
2026
·
Ángel Ramírez-Fernández
, Adham S. Bear
, et al.
·
Journal of Hematology & Oncology
First Case of TAP1 Deficiency with EBV B-Cell Lymphoma Treated with Cellular Immunotherapy
2026
·
Francisco Javier Bermejo-Olivera
, Miriam Velasco-Sidro
, et al.
·
Journal of Clinical Immunology
Show more works
View as search
Works count:
6
Citation count:
30
H-index:
3
I10-index:
2
Year
Topic
Type